PSYCHOSOCIAL/BEHAVIORAL

(281) Experiences and Decision-Making with Highly Effective CFTR Modulator Therapy: Preliminary Findings from a Qualitative Study

(282) Caregivers of Infants with CF and CRMS with Prior History of Depression or Anxiety Report Difficulties Related to Sleepiness

(283) Expectations and experiences of adolescents with cystic fibrosis: influence of Elexacaftor/Tezacaftor/Ivacaftor on treatment adherence and identity

(284) “You’re not alone”: Implementation and challenges of a virtual CF parent group

(286) A Multidisciplinary Approach to Assessing Reproductive Health Knowledge in adolescent patients with Cystic Fibrosis: Considerations for a post Trikafta World

(287) Psychotropic medication in end-stage patients with cystic fibrosis

(288) Treatment targets in the psychological care of youth with CF

(289) Training CF care team members to deliver a behavioral telehealth intervention to improve adherence in adolescents and young adults with CF

(290) Body Image Insights among adolescents with Cystic Fibrosis in the modulator era

(291) Development and Validation of the CF Stress Questionnaire: A CF-Specific Measure of Perceived Stress

(292) Effects of Triple Combination Therapy on Quality of Life and Psychosocial Outcomes: A Longitudinal Study

(293) Longitudinal Mental Health Trends in Pediatric Cystic Fibrosis

(294) National Assessment of School Resources in Cystic Fibrosis Care Centers

(295) Measuring caregiver stress and perceived self-efficacy during a worldwide pandemic

(296) Positive longitudinal effects of elexacaftor/tezacaftor/ivacaftor across multiple domains of physical and mental health: Pre-post findings in an Italian sample

(297) Mental Health Symptoms & Physical Health Outcomes in Youth with CF

(298) Co-Designing an Acceptance and Commitment Therapy Telehealth Group Intervention for Adolescents with Cystic Fibrosis

(299) Parental Stress, Feeding Style, and Mealtime Behaviors of Children with Cystic Fibrosis

(301) A multi-center study exploring the impact of co-adherence to inhaled therapies on FEV₁ response in people with CF taking Trikafta within the CFHealthHub learning health system.

(302) Collaborative research to define patient‑reported experience measures of the cystic fibrosis care pathway in France: the ExPaParM study

(303) A Systematic Review of Behavioral Change Techniques in Mobile Health Interventions for Adherence or Self-Management: Application to People with CF

(304) Utilizing Network Learning Models to Facilitate Best Practices for Successful Conversations Prompted from the Daily Care Check-In

(305) Empowerment in adolescents and young adults with CF

(306) Understanding body image perceptions and Trikafta use in adolescents and young adults living with cystic fibrosis

(308) Bright Beginnings: Early intervention for parents of newly diagnosed infants

(309) Preliminary Reliability and Predictive Validity of the CF Self-Efficacy and Stressors Scale for Caregivers

(310) A Photovoice Exploration Of Parenthood Among People With Cystic Fibrosis

(311) A Qualitative Exploration of Parenthood Experiences and Needs Among People with Cystic Fibrosis

(313) Breastfeeding & Nutritional Counseling in Early Cystic Fibrosis Care: An Opportunity for Shared Decision-Making

(314) CF Legal Information Hotline: A Reliable Resource for the CF Community During the Pandemic and Beyond

(315) CF mental health research priorities: Qualitative content analysis of CF community and provider survey

(316) Depression and anxiety scores post HEMT in pandemic times in adult CF clinic

(317) Evaluating the acceptability and utility of the Internet-delivered Cystic Fibrosis Mental Health Prevention, Wellness, and Resource program.

(318) Exploring Wellness in the CF Community

(319) Fatigue and Poor Sleep Quality Still Prevalent Even in Setting Of Elexacaftor/Tezacaftor/Ivacaftor

(320) Fertility and Family Planning Perspectives among Men with Cystic Fibrosis

(323) It’s time to be blunt – a deeper investigation of attitudes and usage of marijuana, cannabidiol, and cigarettes in the Cystic Fibrosis community

(324) National Implementation of depression and anxiety screening and treatment at US CF Centers: What predicts success?

(326) Prevalence of substance use in adult cystic fibrosis patients

(327) Procedural distress and intervention in children with CF ages 6-11: A single center interdisciplinary quality initiative

(328) Research Beliefs and Barriers to Evidence Based Practice Among CF Social Workers

(329) Sleep Aids, Sleep Quality, And Daytime Sleepiness In Emerging Adults With Cystic Fibrosis (CF) On CF Transmembrane Conductance Regulator (CFTR) Modulator Therapy

(330) The formation of a virtual CF support group: Connecting with other parents’ experiences (CF COPE)

(331) UPLIFT: Preliminary results of a web-based group mental health intervention study in CF

(333) What is the Impact of Journaling Therapy on Pediatric Patients with Cystic Fibrosis

(334) Who Are We Excluding? An RCT for Adults With Cystic Fibrosis That Includes Those With Moderate to Severe Symptoms of Depression and Anxiety